标题：全国药品安全形势总体稳定，监管工作迈上新台阶
据本报北京电，记者从日前召开的全国药品监督管理工作会议上获悉，2023年，我国药品监管工作取得了显著成效，药品安全底线持续筑牢，全国药品安全形势保持总体稳定。
会议指出，过去一年，我国药品监管部门坚决贯彻落实党中央、国务院决策部署，坚持以人民为中心的发展思想，全面加强药品监管，确保药品安全底线。在此背景下，全国药品安全形势保持总体稳定，为保障人民群众生命安全和身体健康提供了有力保障。
会议强调，2023年，我国药品监管工作将迈上新台阶。一方面，将继续深化药品监管体制改革，完善药品监管法律法规体系，提高药品监管效能。另一方面，将进一步加强药品质量安全监管，严厉打击各类违法违规行为，确保药品安全底线不断筑牢。
此外，会议还提出，要加强药品科技创新，推动药品产业高质量发展。通过加大研发投入，推动药品产业结构调整，提高药品质量和疗效，满足人民群众日益增长的健康需求。
总之，我国药品监管工作在新的一年里将取得更大的突破，为保障人民群众的生命安全和身体健康提供更加有力的保障。
英语如下：
Title: Stable Drug Safety Situation in 2023, Regulatory Work Reaches New Heights
Keywords: Drug safety, Regulatory work, Overall stability
News Content: Title: Overall Stability of National Drug Safety, Regulatory Work Has Reached a New Level
According to our Beijing correspondent, it was learned from the recent National Conference on Drug Supervision and Administration that in 2023, China’s drug regulatory work has achieved remarkable results, continuously strengthening the bottom line of drug safety, and maintaining an overall stable drug safety situation nationwide.
The meeting pointed out that in the past year, China’s drug regulatory authorities resolutely implemented the decisions and arrangements of the Party Central Committee and the State Council, adhered to the people-centered development concept, comprehensively strengthened drug regulation, and ensured the bottom line of drug safety. Against this background, the national drug safety situation remained overall stable, providing a strong guarantee for protecting the lives and health of the people.
The meeting emphasized that in 2023, China’s drug regulatory work will reach a new level. On the one hand, it will continue to deepen the reform of the drug regulatory system, improve the legal system for drug regulation, and enhance the efficiency of drug regulation. On the other hand, it will further strengthen the supervision of drug quality and safety, severely crack down on all kinds of illegal and unlawful behaviors, and continuously strengthen the bottom line of drug safety.
In addition, the meeting also proposed to strengthen drug scientific and technological innovation and promote the high-quality development of the pharmaceutical industry. By increasing investment in research and development, promoting structural adjustments in the pharmaceutical industry, improving drug quality and efficacy, and meeting the growing health needs of the people.
In summary, China’s drug regulatory work will achieve greater breakthroughs in the new year, providing more powerful guarantees for protecting the lives and health of the people.
【来源】http://www.chinanews.com/gn/2024/01-16/10146865.shtml
Views: 1